Hobbs Group Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Hobbs Group Advisors's ABBV Position: Q2 2026 in Review
Hobbs Group Advisors reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $4.3K and leaving 1,609 shares worth $405K. The position accounts for 0.11% of the portfolio, ranked #123.
Hobbs Group Advisors first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $814K in Q1 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Hobbs Group Advisors held 1,609 shares of AbbVie worth $405K as of Q2 2026.
- Hobbs Group Advisors sold 20 AbbVie shares in Q2 2026, an estimated $4.3K.
- AbbVie made up 0.11% of Hobbs Group Advisors's portfolio in Q2 2026, its #123 holding.
- Hobbs Group Advisors first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
- Hobbs Group Advisors's AbbVie position peaked at $814K in Q1 2025.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Hobbs Group Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.